SHSE:688192 (China)
Â
Class A
Â¥
42.78
(+1.74%)
Dec 27
Business Description
Dizal (Jiangsu) Pharmaceutical Co Ltd
ISIN : CNE1000055W8
Share Class Description:
SHSE:688192: Class ACompare
Compare
Traded in other countries / regions
688192.China IPO Date
2021-12-10Description
Dizal (Jiangsu) Pharmaceutical Co Ltd is engaged in the research and development, production and sales of innovative drugs.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.89 | |||||
| Equity-to-Asset | 0.26 | |||||
| Debt-to-Equity | 2.11 | |||||
| Debt-to-EBITDA | -0.99 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 4.86 | |||||
| Beneish M-Score | 4.1 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 42.8 | |||||
| 3-Year EBITDA Growth Rate | -7.8 | |||||
| 3-Year EPS without NRI Growth Rate | -11.7 | |||||
| 3-Year FCF Growth Rate | -12.4 | |||||
| 3-Year Book Growth Rate | -11.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 62.17 | |||||
| Future 3-5Y Total Revenue Growth Rate | 176.92 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.96 | |||||
| 9-Day RSI | 35.44 | |||||
| 14-Day RSI | 39.43 | |||||
| 6-1 Month Momentum % | 29.36 | |||||
| 12-1 Month Momentum % | 3.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.72 | |||||
| Quick Ratio | 1.66 | |||||
| Cash Ratio | 1.43 | |||||
| Days Inventory | 1144.38 | |||||
| Days Sales Outstanding | 58.57 | |||||
| Days Payable | 5938.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.3 | |||||
| Shareholder Yield % | -2.82 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 97.64 | |||||
| Operating Margin % | -237.22 | |||||
| Net Margin % | -214.87 | |||||
| FCF Margin % | -221.22 | |||||
| ROE % | -114.22 | |||||
| ROA % | -52.26 | |||||
| ROIC % | -108.05 | |||||
| ROC (Joel Greenblatt) % | -700.83 | |||||
| ROCE % | -84.61 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 45.17 | |||||
| PB Ratio | 41.53 | |||||
| EV-to-EBIT | -19.33 | |||||
| EV-to-EBITDA | -19.33 | |||||
| EV-to-Revenue | 45.13 | |||||
| EV-to-FCF | -20.7 | |||||
| Earnings Yield (Greenblatt) % | -5.17 | |||||
| FCF Yield % | -4.83 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Dizal (Jiangsu) Pharmaceutical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 389.638 | ||
| EPS (TTM) (Â¥) | -2.04 | ||
| Beta | 1.23 | ||
| Volatility % | 48.29 | ||
| 14-Day RSI | 39.43 | ||
| 14-Day ATR (Â¥) | 1.732713 | ||
| 20-Day SMA (Â¥) | 45.338 | ||
| 12-1 Month Momentum % | 3.2 | ||
| 52-Week Range (Â¥) | 24.82 - 51.15 | ||
| Shares Outstanding (Mil) | 417.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Dizal (Jiangsu) Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Dizal (Jiangsu) Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Dizal (Jiangsu) Pharmaceutical Co Ltd Frequently Asked Questions
What is Dizal (Jiangsu) Pharmaceutical Co Ltd(SHSE:688192)'s stock price today?
The current price of SHSE:688192 is ¥42.78. The 52 week high of SHSE:688192 is ¥51.15 and 52 week low is ¥24.82.
When is next earnings date of Dizal (Jiangsu) Pharmaceutical Co Ltd(SHSE:688192)?
The next earnings date of Dizal (Jiangsu) Pharmaceutical Co Ltd(SHSE:688192) is .
Does Dizal (Jiangsu) Pharmaceutical Co Ltd(SHSE:688192) pay dividends? If so, how much?
Dizal (Jiangsu) Pharmaceutical Co Ltd(SHSE:688192) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers